Dr. Michelle Sarah Mourad, MD

Dr. Mourad practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Mourad's NPI, 1073712261, was assigned on July 17, 2007. Dr. Mourad graduated from New York University School of Medicine in 2005. Dr. Mourad holds California license A98521.

Dr. Mourad's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Mourad's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Mourad is also affiliated with UCSF Health Stanyan Hospital. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Mourad to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mourad practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mourad's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mourad is board certified in internal medicine by the American Board of Internal Medicine. Dr. Mourad is licensed in California.

Dmand AI lists acute respiratory failure, bile duct problems, cellulitis, gastrointestinal inflammation, kidney failure, pneumonia and respiratory infection, pulmonary embolism and sepsis among the conditions Dr. Mourad treats.

CMS data shows 175 Medicare services from Dr. Mourad across 5 procedure codes in 2024, for 57 Medicare patients. Medicare paid $17,467 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 57 Medicare patients who saw Dr. Mourad in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 53% are also on Medicaid. Their average risk score is 3.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mourad's median patient age at 74, with 47% women.

In 2024, Dr. Mourad wrote 83 Medicare Part D claims for 17 patients. 73% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $1,519 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mourad for performance year 2024, reported as part of a group. Dr. Mourad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 67 papers to Dr. Mourad, published from 2007 to 2024. 2023 was the busiest year, with 8. The most frequent topics are Patient Discharge, Academic Medical Centers and Internal Medicine. Dr. Mourad has published most often in J Hosp Med. Dr. Mourad's most frequent co-authors are Sumant R. Ranji, MD, Timothy Judson, MD and Andrew D. Auerbach, MD.

Dr. Mourad graduated from New York University School of Medicine in 2005. Dr. Mourad is a member of SHM.

Dr. Mourad is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.